Skip Navigation

Cardiovascular Research 2004 64(3):507-515; doi:10.1016/j.cardiores.2004.07.020
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Porter, K. E.
Right arrow Articles by Ball, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porter, K. E.
Right arrow Articles by Ball, S. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Tumor necrosis factor {alpha} induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin

Karen E. Portera,*, Neil A. Turnera, David J. O'Reganb and Stephen G. Balla

aInstitute for Cardiovascular Research, Academic Unit for Cardiovascular Medicine, Worsley Building, University of Leeds, Leeds LS2 9JT, UK
bDepartment of Cardiac Surgery, The Yorkshire Heart Centre, Leeds General Infirmary, Leeds LS1 3EX, UK

* Corresponding author. Tel.: +44 113 3434807; fax: +44 113 3434803. Email address: medkep{at}leeds.ac.uk

Objective: Tumor necrosis factor {alpha} (TNF{alpha}) is implicated in myocardial remodeling, a process in which activated cardiac fibroblasts (myofibroblasts) secrete matrix-degrading metalloproteinases (MMPs) and undergo increased proliferation and invasion. Statins are cholesterol-lowering drugs that also have direct cellular effects, which may underlie their ability to reduce myocardial remodeling. This study investigated the effect of TNF{alpha} on human cardiac myofibroblast proliferation, invasion and MMP-9 secretion, and determined whether these properties were modulated by simvastatin.

Methods: Human cardiac myofibroblasts were cultured from right atrial appendage. TNF receptor expression was quantified by immunoblotting. Cell proliferation, invasion, MMP-9 secretion and MMP-9 mRNA expression were determined by cell counting, Matrigel-coated modified Boyden chamber assays, gelatin zymography and RT-PCR, respectively.

Results: Human atrial myofibroblasts expressed the TNF-RI and TNF-RII receptor subtypes. TNF{alpha} (1 ng/ml) induced a 23.1±3.9% increase in cell number after 4 days (P<0.001). Additionally, TNF{alpha} (1–10 ng/ml) significantly (P<0.01) increased myofibroblast invasion, with a concomitant increase in MMP-9 secretion, that was due to increased MMP-9 mRNA levels. Using TNF-R-specific neutralizing antibodies, we determined that these cellular effects of TNF{alpha} were predominantly TNF-RI-mediated. Simvastatin (0.1–10 µmol/l) concentration dependently inhibited TNF{alpha}-induced myofibroblast proliferation, invasion and MMP-9 secretion.

Conclusions: TNF{alpha}, acting predominantly via the TNF-R1 receptor, increased human atrial myofibroblast proliferation, invasion and MMP-9 secretion, all of which were inhibited by simvastatin. Inhibition of cytokine-induced cardiac myofibroblast activation by statins provides a rationale for their use in patients with cardiac pathologies characterized by adverse myocardial remodeling.

KEYWORDS Tumor necrosis factor {alpha}; Human atrial myofibroblast; MMP-9

Time for primary review 28 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 jvdiHome page
V. Grieco, C. Locatelli, E. Riccardi, and P. Brambilla
A case of two different tumors in the heart of a dog
J Vet Diagn Invest, May 1, 2008; 20(3): 365 - 368.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.